Stephen Brady
Chairman
Tempest Therapeutics, Inc. (TPST)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-11-19–present
-
2021-01-01–2026-05-22
-
2021-01-01–2026-05-22
-
Start not stated–2026-02-03
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Tempest Therapeutics, Inc. (TPST) | Chief Executive Officer and President | $600,000 | $1,872,299 |
| 2023 | Tempest Therapeutics, Inc. (TPST) | Chief Executive Officer and President | $567,000 | $7,007,407 |
| 2022 | Tempest Therapeutics, Inc. (TPST) | Chief Executive Officer and President | $530,000 | $1,514,366 |
| 2021 | Tempest Therapeutics, Inc. (TPST) | Chief Executive Officer | $475,283 | $714,721 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.